Ever Fortune.AI Co (6841) Fair Value & Analysis
Healthcare · TW · Market cap 5.5B TWD
Fair value as of: Jul 21, 2026
From 17 valuation models · updated 20 days ago
Share price −12.8% over the past month.
A solid business, but screening 74% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (14.46 TWD). The favourable scenario is already priced in.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
59‑month range 53.50 TWD – 191.16 TWD · fair‑value band 9.91 TWD – 14.46 TWD · the 56.40 TWD price screens above the 14.46 TWD fair value. Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Ever Fortune.AI Co (6841) currently trades at 56.40 TWD, while our model-based Fair Value estimate is 14.46 TWD, implying the stock looks roughly 74.4% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Ever Fortune.AI Co generated revenue of 376M TWD at a net margin of 24.0%. Revenue declined 3.6% year over year. It earns a return on equity of 5.2%. The balance sheet holds a net cash position of 228M TWD. Fundamentals as of Jul 21, 2026
Our scenario range runs from 9.91 TWD (bear case) to 14.46 TWD (bull case); at 56.40 TWD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at -74%, 6841 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 17 models by family
Widest divergence: Growth Earnings (39.80 TWD) versus Economic Profit (9.56 TWD). Highest evidence: Residual Income (76).
Notify me when 6841 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 53 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China.
Full company description
Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China. The company offers radiation therapy organ, head and neck organ delineation system, bone scintigraphy computer-aided detection platform, cerebral hemorrhage detection system, myocardial perfusion image analysis and reporting system, ECG analysis software, acute aortic syndrome, detection system, acute myocardial infarction detection software, heart-to-chest ratio estimation system, artificial intelligence assisted chest X-ray diagnosis system, bone age auxiliary diagnosis system, and image recording and transmission system. Ever Fortune.AI Co., Ltd. was founded in 1998 and is based in Taichung, Taiwan. Ever Fortune.AI Co., Ltd. is a subsidiary of An Ji Biomedical Corporation.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ever Fortune.AI Co reported revenue of 379M TWD in FY2025 versus 38.2M TWD in FY2021, a compound +77.4%/yr. Reported net income was 83.4M TWD in FY2025.
6841 screens 74% overvalued. Compare with Veeva Systems Inc →
Peer Group
Health Information Services · 126 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $190.12 | $95.12 | -50% |
| Pro Medicus Limited PME | A$194.84 | A$23.74 | -88% |
| BrightSpring Health Services, Inc BTSG | $68.16 | $21.31 | -69% |
| HealthEquity, Inc HQY | $97.67 | $56.63 | -42% |
| Hinge Health, Inc HNGE | $88.80 | $24.03 | -73% |
| 10x Genomics, Inc TXG | $45.75 | $17.18 | -62% |
| Waystar Holding WAY | $22.69 | $12.86 | -43% |
| Doximity, Inc DOCS | $22.21 | $17.18 | -23% |
| Privia Health Group PRVA | $28.10 | $5.30 | -81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,846 | ₹860.28 | -53% |
Compare Ever Fortune.AI Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ever Fortune.AI Co (6841) overvalued or undervalued?
What is the fair value of 6841?
What is the quality score of 6841?
What is the revenue of Ever Fortune.AI Co (6841)?
What is the net profit margin of 6841?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Ever Fortune.AI Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.